Roche Kept at Buy as BofA Notes 'Solid' Efficacy Data for Multiple Sclerosis Drug
Published on 02/09/2026 at 06:11 pm +03
MT Newswires
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330.00 CHF | -1.55% |
|
-8.03% | +0.55% |
| 07:00pm | Regenxbio's Duchenne gene therapy shows improved muscle function in trial | RE |
| 04:45pm | AlphaValue/Baader Europe Upgrades Roche to Add Rating, Trims PT | MT |
Employees
103,249
Sector
Pharmaceuticals
Calendar
03-12 -
Ex-dividend date - 9.8 CHF
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
AA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
335.20CHF
Average target price
364.79CHF
Spread / Average Target
+8.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- Roche Kept at Buy as BofA Notes 'Solid' Efficacy Data for Multiple Sclerosis Drug
Select your edition
All financial news and data tailored to specific country editions
